Home Rznomics

Rznomics

In operation
PreIPO
Gene Therapy Developer

Basic Information

Algenomics Co., Ltd. is a research company that develops gene therapies using RNA, aiming to create new biopharmaceuticals for cancer and intractable diseases with significant unmet medical needs. The company develops therapeutic products for treating various cancers, degenerative neurological disorders, and hereditary diseases, enabling doctors to treat conditions such as cancer and Alzheimer's disease.
Rznomics, Inc.
GyeonggiProvince,SouthKorea
15~50 people
January 01, 2017
rznomics@rznomics.com